Trial intelligence / Profile preview

Morphine for Dyspnea in Interstitial Lung Disease

NCT02622022Phase 4Completed

Sponsor
Aarhus University
Start
Jan 2016
Primary completion
Feb 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of morphine hydrochloride in Dyspnea, sponsored by Aarhus University. Started Jan 2016; status: completed.

02

Drugs

morphine hydrochloride
03

Conditions

Dyspnea

Beyond the preview

Go deeper on NCT02622022.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02622022.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call